Neoadjuvant Sintilimab and Chemotherapy for Resectable Stage IIIA Non-small-cell Lung Cancer. Zhang P, Dai J, Sun F, Xia H, et al. Ann Thorac Surg 2022 Feb 14. pii: S0003-4975(22)00191.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang P, Dai J, Sun F, Xia H, et al. Neoadjuvant Sintilimab and Chemotherapy for Resectable Stage IIIA Non-small-cell Lung Cancer. Ann Thorac Surg 2022 Feb 14. pii: S0003-4975(22)00191.
PMID: 35176262